Results of the November 2020 Emerging Scholar Awards Competition

We are pleased to announce the results of the inaugural round of the Emerging Scholar Awards (ESA) competition. Launched in December 2019, the ESA program aims to establish and advance promising early career scientists and clinician scientists from across Canada with a focused commitment to undertaking cancer research.

39 Letters of Intent were submitted to the competition. Following a scientific review, 25 were invited to submit full applications. 20 eligible full applications were received and evaluated by a review panel comprised of scientific reviewers and patient/survivor/caregiver representatives. 15 grants have been approved for funding – 75% of all full applications received – representing a total investment of more than $8.5 million. Each grant is valued at up to $600,000 over a 5-year term.

Please note:

• Amounts listed below represent the total dollars awarded and may include funds for salaries, supplies, equipment, professional development and/or teaching/clinical buy-out time.
• The start date for these grants is May 1, 2021.
• Only the Principal Investigator is named in this listing. Co-Applicants and/or Additional Authors may also be associated with these grants.

Below is a list of newly awarded ESA grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants have been informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Last modified on: April 22, 2021